Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00462644 · ClinicalTrials.gov registry record · NA
Evaluation of Etomidate on Adrenal Function in Trauma Patients
A NA study, sponsored by University of Tennessee.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT00462644 is a NA study that has completed, run by University of Tennessee. The registered enrollment target is 30 participants.
The verdict
NCT00462644, a NA study, has completed, sponsored by University of Tennessee.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
Trauma patients are at increased risk for adrenal function insufficiency. A commonly used agent for rapid sequence intubation (RSI) is known to decrease adrenal function. We want to determine the incidence of adrenocortical insufficiency and its significance during the first 24 hours of resuscitation following RSI in trauma patients.
Interventions
- DRUG RSI sedation with etomidate/succinylcholine
- DRUG RSI sedation with fentanyl/midazolam/succinylcholine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2006-02 |
| Est. Completion | 2006-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00462644
The ClinicalTrials.gov registry entry for NCT00462644 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Tennessee, which has 96 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which RSI sedation with etomidate/succinylcholine is the first listed.
NCT00462644 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00462644 about?
NCT00462644 is a clinical study titled "Evaluation of Etomidate on Adrenal Function in Trauma Patients". Trauma patients are at increased risk for adrenal function insufficiency. A commonly used agent for rapid sequence intubation (RSI) is known to decrease adrenal function. We want to determine the incidence of adrenocortical insufficiency and its significance during the first 24 hours of resuscitatio...
What is the current status of trial NCT00462644?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2006-02. Estimated completion is 2006-09.
What interventions are being tested in trial NCT00462644?
The interventions under investigation include: RSI sedation with etomidate/succinylcholine (DRUG), RSI sedation with fentanyl/midazolam/succinylcholine (DRUG).
Who is sponsoring clinical trial NCT00462644?
This trial is sponsored by University of Tennessee, which has 96 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.